The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Pulmonary Drug Delivery Devices Market During 2026–2030?
The pulmonary drug delivery devices market has experienced significant growth in recent years. This market is projected to expand from $52.8 billion in 2025 to $56.49 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.0%. The historical growth is attributable to an increasing prevalence of respiratory diseases, the rising adoption of inhalation therapies, the expansion of asthma and COPD treatment programs, improvements in inhaler design technologies, and a growing awareness of pulmonary drug delivery.
The pulmonary drug delivery devices market size is anticipated to experience substantial growth in the next few years, set to expand to $71.9 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This projected increase within the forecast period can be attributed to several factors: a rising demand for personalized respiratory therapies, greater adoption of digital health-integrated inhalers, the expansion of home-based respiratory care, an increased emphasis on non-invasive drug delivery methods, and ongoing innovation in inhalation technologies. Furthermore, major trends for this period include the growing uptake of smart and connected inhaler devices, an increasing need for targeted pulmonary drug delivery, the wider use of mesh and ultrasonic nebulizers, the proliferation of combination drug-device products, and a stronger focus on enhancing patient adherence.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
Which Economic Or Industry Drivers Are Impacting The Pulmonary Drug Delivery Devices Market?
The increasing incidence of respiratory disorders is projected to boost the expansion of the pulmonary drug delivery devices market in the future. Respiratory disorders are conditions or diseases impacting the lungs and airways, thereby affecting human respiration. The growing occurrence of these disorders is attributed to several factors such as rising air pollution levels, increasing smoking rates, urbanization, climate change, and an aging population. Pulmonary drug delivery devices are vital in managing respiratory disorders, as they facilitate the direct administration of medications to the lungs. For instance, in December 2023, a research study released by JAMA Network Open, a medical journal from the American Medical Association, predicted that the global burden of chronic obstructive pulmonary disease (COPD) could lead to nearly 600 million cases worldwide by 2050, indicating a 23% increase in prevalence. Therefore, the escalating prevalence of COPD is a key driver for the growth of the pulmonary drug delivery devices market.
How Are The Various Segments Of The Pulmonary Drug Delivery Devices Market Categorized?
The pulmonary drug delivery devices market covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
What Trends Are Affecting The Expansion Of The Pulmonary Drug Delivery Devices Market?
Major companies operating in the pulmonary drug delivery devices market are engaged in developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) functions as a medical device for delivering liquid medication in the form of aerosolized mist to patients experiencing respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries LP, a US-based healthcare company, introduced the Hudson RCI TurboMist small-volume nebulizer. This innovative device is engineered to administer medication treatments swiftly, requiring as little as three minutes. The advanced nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, thereby reducing treatment times by about 70%. This enhancement in medication delivery significantly shortens treatment durations, benefiting healthcare providers by optimizing patient throughput and improving the patient experience through abbreviated therapy sessions.
Which Major Firms Influence Developments In The Pulmonary Drug Delivery Devices Market?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.
Read the full pulmonary drug delivery devices market report here:
What Are The Top-Performing Regions Within The Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pulmonary Drug Delivery Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp
Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2026, By The Business Research Company
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Injectable Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model